EFG Asset Management Americas Corp. Has $10.36 Million Stake in CME Group Inc. $CME

EFG Asset Management Americas Corp. lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 37,598 shares of the financial services provider’s stock after selling 1,102 shares during the period. CME Group comprises about 1.9% of EFG Asset Management Americas Corp.’s holdings, making the stock its 9th biggest position. EFG Asset Management Americas Corp.’s holdings in CME Group were worth $10,363,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. AIA Group Ltd increased its holdings in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 2,510 shares during the last quarter. Lockheed Martin Investment Management Co. lifted its holdings in CME Group by 34.1% during the first quarter. Lockheed Martin Investment Management Co. now owns 58,690 shares of the financial services provider’s stock valued at $15,570,000 after purchasing an additional 14,910 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in CME Group by 20.1% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 8,894 shares of the financial services provider’s stock worth $2,359,000 after purchasing an additional 1,491 shares during the period. Truist Financial Corp boosted its position in CME Group by 10.0% during the second quarter. Truist Financial Corp now owns 64,939 shares of the financial services provider’s stock worth $17,898,000 after purchasing an additional 5,914 shares during the period. Finally, Bank of Nova Scotia Trust Co. boosted its holdings in CME Group by 4.9% in the 1st quarter. Bank of Nova Scotia Trust Co. now owns 25,820 shares of the financial services provider’s stock worth $6,850,000 after buying an additional 1,201 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William R. Shepard purchased 262 shares of the company’s stock in a transaction on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders sold 14,043 shares of company stock worth $3,791,486 over the last quarter. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

NASDAQ:CME opened at $272.49 on Thursday. The company has a market capitalization of $98.26 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 4.41 and a beta of 0.38. The business has a 50 day moving average of $268.27 and a 200 day moving average of $272.82. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $224.62 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the firm posted $2.68 earnings per share. The business’s revenue was down 3.0% compared to the same quarter last year. On average, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be issued a dividend of $1.25 per share. The ex-dividend date is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is currently 48.45%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CME shares. JPMorgan Chase & Co. upped their price target on CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research report on Tuesday, October 14th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Morgan Stanley boosted their target price on CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a research report on Thursday, October 23rd. Barclays lowered their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 8th. Finally, The Goldman Sachs Group lifted their price target on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research report on Thursday, October 23rd. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $287.65.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.